| 41 |
|
Cooperation of Two Mutant p53 Alleles Contributes to Fas Resistance of Prostate Carcinoma Cells/
|
Gurova, K. V
|
Williams and Wilkins
|
2003
|
|
|
|
| 42 |
|
Cooperative Effect between Immunotherapy and Antiangiogenic Therapy Leads to Effective Tumor Rejection in Tolerant Her-2/neu Mice/
|
Cuadros, C
|
Williams and Wilkins
|
2003
|
|
|
|
| 43 |
|
Correction - 61: 6388-6393, 2001./
|
Jaiswal, M
|
Williams and Wilkins
|
2001
|
|
|
|
| 44 |
|
Correction // A Bateman et al., Cancer Res., 60: 2492-2497, 2000/
|
|
Williams and Wilkins
|
2000
|
|
|
|
| 45 |
|
Correction - Cancer Res., 60: 2492-2497, 2000/
|
Bateman, A
|
Williams and Wilkins
|
2000
|
|
|
|
| 46 |
|
Correction // Cancer Res. 60: 4556-4560, 2000/
|
Hansen-Algenstaedt, N
|
Williams and Wilkins
|
2001
|
|
|
|
| 47 |
|
Correction - S A Gayther et al., Cancer Res., 60: 4513-4518, 2000/
|
Gayther, S A
|
Williams and Wilkins
|
2001
|
|
|
|
| 48 |
|
Corrections - X Huang et al., Cancer Res., 61: 478-491, 2001. . S-H Song et al., Cancer Res., 61: 4628-4635, 2001./
|
|
Williams and Wilkins
|
2001
|
|
|
|
| 49 |
|
Correlating Genetic Aberrations with World Health Organization-defined Histology and Stage across the Spectrum of Thymomas/
|
Inoue, M
|
Williams and Wilkins
|
2003
|
|
|
|
| 50 |
|
Correspondence re: B-L. Adam et al., Serum Protein Fingerprinting Coupled with a Pattern-matching Algorithm Distinguishes Prostate Cancer from Benign Prostate Hyperplasia and Healthy Men. Cancer Res., 62: 3609-3614, 2002/
|
Stattin, P
|
Williams and Wilkins
|
2003
|
|
|
|
| 51 |
|
Correspondence re: J. B. de Kok et al., DD3, A Very Sensitive and Specific Marker to Detect Prostate Tumors. Cancer Res., 62: 2695-2698, 2002/
|
Gandini, O
|
Williams and Wilkins
|
2003
|
|
|
|
| 52 |
|
Correspondence re: Welzel et al., Cancer Res., 61: 1629-1636/
|
Roulland, S
|
Williams and Wilkins
|
2003
|
|
|
|
| 53 |
|
Cotylenin A, a Differentiation-inducing Agent, and IFN-alpha Cooperatively Induce Apoptosis and Have an Antitumor Effect on Human Non-Small Cell Lung Carcinoma Cells in Nude Mice/
|
Honma, Y
|
Williams and Wilkins
|
2003
|
|
|
|
| 54 |
|
CpG-A and B Oligodeoxynucleotides Enhance the Efficacy of Antibody Therapy by Activating Different Effector Cell Populations/
|
van Ojik, H. H
|
Williams and Wilkins
|
2003
|
|
|
|
| 55 |
|
Critical Impact of the Kinetics of Dendritic Cells Activation on the in Vivo Induction of Tumor-specific T Lymphocytes/
|
Camporeale, A
|
Williams and Wilkins
|
2003
|
|
|
|
| 56 |
|
CrkI Adapter Protein Modulates Cell Migration and Invasion in Glioblastoma/
|
Takino, T
|
Williams and Wilkins
|
2003
|
|
|
|
| 57 |
|
Cyclooxygenase-2 Expression and Effect of Celecoxib in Gastric Adenomas of Trefoil Factor 1-deficient Mice/
|
Saukkonen, K
|
Williams and Wilkins
|
2003
|
|
|
|
| 58 |
|
Cyclooxygenase-2 Expression Is Related to Nuclear Grade in Ductal Carcinoma in Situ and Is Increased in Its Normal Adjacent Epithelium/
|
Shim, V
|
Williams and Wilkins
|
2003
|
|
|
|
| 59 |
|
Cyclooxygenase-2 Is Up-Regulated by Interleukin-1beta in Human Colorectal Cancer Cells via Multiple Signaling Pathways/
|
Liu, W
|
Williams and Wilkins
|
2003
|
|
|
|
| 60 |
|
Cysteine-rich Fibroblast Growth Factor Receptor 1, a New Marker for Precancerous Epithelial Lesions Defined by the Human Monoclonal Antibody PAM-1/
|
Brandlein, S
|
Williams and Wilkins
|
2003
|
|
|
|